A detailed history of Group One Trading, L.P. transactions in Cel Sci Corp stock. As of the latest transaction made, Group One Trading, L.P. holds 23,242 shares of CVM stock, worth $17,663. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,242
Previous 40,944 43.23%
Holding current value
$17,663
Previous $78,000 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$1.11 - $1.85 $19,649 - $32,748
-17,702 Reduced 43.23%
23,242 $26,000
Q1 2024

May 10, 2024

SELL
$1.63 - $3.08 $48,508 - $91,660
-29,760 Reduced 42.09%
40,944 $78,000
Q4 2023

Feb 14, 2024

BUY
$1.07 - $3.07 $54,572 - $156,576
51,002 Added 258.87%
70,704 $192,000
Q3 2023

Nov 09, 2023

SELL
$1.17 - $2.86 $81,980 - $200,397
-70,069 Reduced 78.05%
19,702 $24,000
Q2 2023

Aug 09, 2023

SELL
$2.11 - $2.83 $207,904 - $278,848
-98,533 Reduced 52.33%
89,771 $216,000
Q1 2023

May 12, 2023

SELL
$2.17 - $3.13 $18,781 - $27,090
-8,655 Reduced 4.39%
188,304 $436,000
Q4 2022

Feb 09, 2023

SELL
$1.99 - $3.52 $47,445 - $83,923
-23,842 Reduced 10.8%
196,959 $462,000
Q3 2022

Nov 09, 2022

SELL
$3.09 - $5.23 $9,968 - $16,871
-3,226 Reduced 1.44%
220,801 $682,000
Q2 2022

Aug 11, 2022

BUY
$2.58 - $4.99 $238,123 - $460,557
92,296 Added 70.06%
224,027 $1.01 Million
Q1 2022

May 12, 2022

BUY
$3.93 - $7.7 $173,556 - $340,047
44,162 Added 50.43%
131,731 $518,000
Q4 2021

Feb 11, 2022

BUY
$7.1 - $12.82 $132,308 - $238,900
18,635 Added 27.03%
87,569 $622,000
Q3 2021

Nov 12, 2021

SELL
$7.64 - $12.49 $720,268 - $1.18 Million
-94,276 Reduced 57.76%
68,934 $758,000
Q2 2021

Aug 10, 2021

BUY
$8.68 - $27.49 $1.42 Million - $4.49 Million
163,210 New
163,210 $1.42 Million
Q3 2019

Nov 12, 2019

SELL
$6.0 - $9.6 $138,660 - $221,856
-23,110 Closed
0 $0
Q2 2019

Aug 09, 2019

BUY
$3.77 - $8.67 $72,044 - $165,683
19,110 Added 477.75%
23,110 $194,000
Q1 2019

May 13, 2019

BUY
$2.58 - $3.54 $10,320 - $14,160
4,000 New
4,000 $14,000

Others Institutions Holding CVM

About CEL SCI CORP


  • Ticker CVM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,367,500
  • Market Cap $33M
  • Description
  • CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...
More about CVM
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.